|
Re: To good to be true?
|
7
|
Resverlogix Corp.
|
Oct 30, 2021 10:34AM
|
|
Re: December 22, 2020.
|
7
|
Resverlogix Corp.
|
Oct 08, 2020 06:31PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
7
|
Resverlogix Corp.
|
Mar 27, 2020 10:19AM
|
|
Q1- March 31, 2022 on SEDAR
|
7
|
Resverlogix Corp.
|
May 14, 2022 11:07AM
|
|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
7
|
Resverlogix Corp.
|
May 09, 2022 12:07PM
|
|
Re: Q1- March 31, 2022 on SEDAR
|
7
|
Resverlogix Corp.
|
May 22, 2022 03:02PM
|
|
Re: Questions about units
|
7
|
Resverlogix Corp.
|
May 18, 2019 06:49AM
|
|
Exempt Distribution 45-106F1
|
7
|
Resverlogix Corp.
|
Mar 27, 2020 12:44PM
|
|
Re: A flash mob metaphor - hoping RVX will start playing 'Ode to Joy'
|
7
|
Resverlogix Corp.
|
Dec 26, 2019 02:33PM
|
|
Re: Another Exempt Distribution -2022-06-02
|
6
|
Resverlogix Corp.
|
Jun 06, 2022 02:50PM
|
|
Re: Biotech Valuation
|
6
|
Resverlogix Corp.
|
Mar 31, 2021 07:06AM
|
|
Re: Stock price
|
6
|
Resverlogix Corp.
|
Apr 25, 2019 04:03PM
|
|
Re: News out - Dosing of First Cancer Patient with a Combination of ZEN-3694 + Bristol Myers Squibb’s Immune Checkpoint Inhibitor OPDIV
|
6
|
Zenith Epigenetics
|
Feb 28, 2022 09:29AM
|
|
Re: TD Zenith Capital Corp | Grey Market : ZHCLF
|
6
|
Zenith Epigenetics
|
Aug 20, 2020 08:14AM
|
|
Re: German drug maker Morphosys to buy Constellation Pharma in $1.7 billion deal
|
6
|
Zenith Epigenetics
|
Jun 04, 2021 10:12AM
|
|
Re: Q1- March 31, 2022 on SEDAR
|
6
|
Resverlogix Corp.
|
May 17, 2022 09:38AM
|
|
Re: Is Resverlogix Legit?
|
6
|
Resverlogix Corp.
|
Jul 28, 2019 06:35AM
|
|
Re: Interesting.
|
6
|
Resverlogix Corp.
|
Nov 23, 2021 11:13AM
|
|
Re: Any day now......
|
6
|
Resverlogix Corp.
|
May 28, 2021 10:15PM
|
|
Re: Eversana ValuationCaseStudy
|
6
|
Resverlogix Corp.
|
Jan 09, 2022 12:20PM
|
